Scientists portray regions of DNA that sway MECP2 expression

Overview

• Post By :


• Source: Baylor College of Medicine


• Date: 19 Mar,2021

Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (NRI) have identified and characterized two regions of DNA required for the proper expression of Mecp2/MECP2 in mice and humans.

These findings, published in Genes & Development, are helping to shed light on the purpose of these DNA regions and how they could be potential targets for diagnostic and therapeutic interventions for intellectual disabilities such as Rett Syndrome and MECP2 Duplication Syndrome.

These two intellectual disabilities are examples of the importance of precise MeCP2 protein levels for good brain function. A decrease in this protein leads to Rett Syndrome, while an increase in this protein causes MECP2 Duplication Syndrome. Both are acute neurological disorders characterized by learning disabilities, characteristics of dementia and motor problems.

Dr. Huda Zoghbi, professor at Baylor, director of the NRI, and a Howard Hughes Medical Institute investigator, underscored the importance of understanding how the amounts of RNA encoding this protein are controlled. Researchers in her laboratory identified two DNA regions that, when mutated, lead to either a decrease or an increase in MECP2 RNA and protein levels, resulting in partial behavioral deficits seen in Rett Syndrome and MECP2 Duplication Syndrome, respectively.

Yingyao Shao, first author on the study and graduate student in the Zoghbi lab, explains that when one of the two DNA regions have been altered, results showed a moderate decrease in MeCP2 levels mimicking molecular and behavioral changes observed in Rett mice models. Alteration of the other DNA area caused a slight increase in MeCP2 protein levels like mice models with dual expression of MeCP2.

These findings provide hope that future treatments targeting these DNA regions could have clinically relevant benefits, even when only slightly correcting MeCP2 protein levels,” said Shao. “Moreover, mutations in either of these two DNA regions are likely to cause intellectual disability or autism in humans, thus it is important to sequence these regions when screening for genetic causes of neurodevelopmental disorders.”

Yingyao Shao, Study First Author and Graduate Student in Zoghbi Lab, Baylor College of Medicine